Among them, two compounds target the P2X7/K+ channel activation pathway: bright blue G (BBG) [60,180,181] and Glyburide (a sulfonylurea currently used in T2D) [60,182], both displaying a restoration of muscle strength in IIM mouse models. This evidence concerns the gene P2RX7 and type 2 diabetes mellitus.